Literature DB >> 34083352

The total number and mass of SARS-CoV-2 virions.

Ron Sender1, Yinon M Bar-On1, Shmuel Gleizer1, Biana Bernshtein2, Avi Flamholz3, Rob Phillips3,4,5, Ron Milo6.   

Abstract

Quantitatively describing the time course of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection within an infected individual is important for understanding the current global pandemic and possible ways to combat it. Here we integrate the best current knowledge about the typical viral load of SARS-CoV-2 in bodily fluids and host tissues to estimate the total number and mass of SARS-CoV-2 virions in an infected person. We estimate that each infected person carries 109 to 1011 virions during peak infection, with a total mass in the range of 1 μg to 100 μg, which curiously implies that all SARS-CoV-2 virions currently circulating within human hosts have a collective mass of only 0.1 kg to 10 kg. We combine our estimates with the available literature on host immune response and viral mutation rates to demonstrate how antibodies markedly outnumber the spike proteins, and the genetic diversity of virions in an infected host covers all possible single nucleotide substitutions.
Copyright © 2021 the Author(s). Published by PNAS.

Entities:  

Keywords:  COVID-19; genetic diversity; variants of concern; viral biomass; viral load

Year:  2021        PMID: 34083352     DOI: 10.1073/pnas.2024815118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  59 in total

1.  The Impact of the Highly Virulent SARS-CoV-2 Gamma Variant on Young Adults in the State of São Paulo: Was It Inevitable?

Authors:  Beny Spira
Journal:  Cureus       Date:  2022-07-01

2.  Modeling Social Distancing and Quantifying Epidemic Disease Exposure in a Built Environment.

Authors:  Chaitra Hegde; Ali Bahrami Rad; Reza Sameni; Gari D Clifford
Journal:  IEEE J Sel Top Signal Process       Date:  2022-01-25       Impact factor: 7.695

3.  Development of a new antigen-based microarray platform for screening and detection of human IgG antibodies against SARS-CoV-2.

Authors:  Sindy Burgold-Voigt; Elke Müller; David Zopf; Stefan Monecke; Sascha D Braun; Katrin Frankenfeld; Michael Kiehntopf; Sebastian Weis; Thomas Schumacher; Mathias W Pletz; Ralf Ehricht
Journal:  Sci Rep       Date:  2022-05-16       Impact factor: 4.996

4.  Synergistic interactions of repurposed drugs that inhibit Nsp1, a major virulence factor for COVID-19.

Authors:  Hung-Teh Kao; Andrew Orry; Michael G Palfreyman; Barbara Porton
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

5.  Modeling recapitulates the heterogeneous outcomes of SARS-CoV-2 infection and quantifies the differences in the innate immune and CD8 T-cell responses between patients experiencing mild and severe symptoms.

Authors:  Budhaditya Chatterjee; Harshbir Singh Sandhu; Narendra M Dixit
Journal:  PLoS Pathog       Date:  2022-06-27       Impact factor: 7.464

6.  Efficacy of the Sentinox Spray in Reducing Viral Load in Mild COVID-19 and Its Virucidal Activity against Other Respiratory Viruses: Results of a Randomized Controlled Trial and an In Vitro Study.

Authors:  Donatella Panatto; Andrea Orsi; Bianca Bruzzone; Valentina Ricucci; Guido Fedele; Giorgio Reiner; Nadia Giarratana; Alexander Domnich; Giancarlo Icardi
Journal:  Viruses       Date:  2022-05-12       Impact factor: 5.818

7.  Simulating COVID-19 classroom transmission on a university campus.

Authors:  Arvin Hekmati; Mitul Luhar; Bhaskar Krishnamachari; Maja Matarić
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-24       Impact factor: 12.779

8.  Strain wars 3: Differences in infectivity and pathogenicity between Delta and Omicron strains of SARS-CoV-2 can be explained by thermodynamic and kinetic parameters of binding and growth.

Authors:  Marko Popovic
Journal:  Microb Risk Anal       Date:  2022-04-12

9.  Fast, Reliable, and Simple Point-of-Care-like Adaptation of RT-qPCR for the Detection of SARS-CoV-2 for Use in Hospital Emergency Departments.

Authors:  Martina Pavletić; Marija Mazor; Mate Lerga; Tatjana Mileta; Jelena Železnjak; Tina Ružić; Sanda Ravlić; Dora Palčevski; Jelena Kirinčić; Silvestar Mežnarić; Ana Mišković; Maja Materljan; Alan Šustić; Berislav Lisnić; Vanda Juranić Lisnić
Journal:  Viruses       Date:  2021-12-02       Impact factor: 5.048

10.  Nitric Oxide: The Missing Factor in COVID-19 Severity?

Authors:  Alexandros Nikolaidis; Ron Kramer; Sergej Ostojic
Journal:  Med Sci (Basel)       Date:  2021-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.